Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Celtaxsys
201 17th Street, Suite 530
Atlanta, GA 30363
Phone: 470-206-0153
http://www.celtaxsys.com/

Celtaxsys is a privately-held drug discovery and development company focused on advancing treatments for serious inflammatory diseases. The company is building a sustainable pipeline of first-in-class immuno-modulators, the most advanced of which is CTX-4430.

Key Contact
NameTitleE-Mail
Greg DuncanCEOgduncan@celtaxsys.com


Funding Events
DateAmountTypeInvestors
06/08/15$45,000,000Series D Domain Associates
Georgia Research Alliance
Lumira Capital
Masters Capital Management
RusnanoMedInvest
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.